Polypharmacy in Early Rheumatoid Arthritis: Impact on Treatment Response and Adverse Event Risk in a multicenter French prospective cohort study

Overview of attention for article published in ACR Open Rheumatology, July 2025

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (74th percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter: 3 X users
guideline: 1 clinical guideline source

bluesky: 1 Bluesky user

Readers on

mendeley: 9 Mendeley

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 16,426 followers.

The findings from the ESPOIR cohort highlight the complexities of managing early rheumatoid arthritis (RA) in the context of polypharmacy. https://t.co/8ngWJ77dwg

Is polypharmacy assoc w/ treatment response & serious AEs in early RA? Data from the French cohort ESPOIR showed polypharmacy was assoc w/ RA disease activity at 1, 5, & 10 years after 1st DMARD initiation, and increased linearly with non-RA med…

https://t.co/aeifl2ZfFt

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.